These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20378653)

  • 1. Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients.
    Bakkal S; Robinson SM; Ordonez CL; Waltz DA; Riley MA
    Microbiology (Reading); 2010 Jul; 156(Pt 7):2058-2067. PubMed ID: 20378653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriocin-mediated competition in cystic fibrosis lung infections.
    Ghoul M; West SA; Johansen HK; Molin S; Harrison OB; Maiden MC; Jelsbak L; Bruce JB; Griffin AS
    Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26311664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host Adaptation Predisposes Pseudomonas aeruginosa to Type VI Secretion System-Mediated Predation by the Burkholderia cepacia Complex.
    Perault AI; Chandler CE; Rasko DA; Ernst RK; Wolfgang MC; Cotter PA
    Cell Host Microbe; 2020 Oct; 28(4):534-547.e3. PubMed ID: 32755549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs.
    Mei M; Thomas J; Diggle SP
    mBio; 2021 May; 12(3):. PubMed ID: 33947755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competition in Biofilms between Cystic Fibrosis Isolates of
    Oluyombo O; Penfold CN; Diggle SP
    mBio; 2019 Jan; 10(1):. PubMed ID: 30696740
    [No Abstract]   [Full Text] [Related]  

  • 7. Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.
    Schwab U; Abdullah LH; Perlmutt OS; Albert D; Davis CW; Arnold RR; Yankaskas JR; Gilligan P; Neubauer H; Randell SH; Boucher RC
    Infect Immun; 2014 Nov; 82(11):4729-45. PubMed ID: 25156735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ANTIBIOTICS SENSITIVITY OF STAPHYLOCOCCUS AUREUS, PSEUDOMONAS AERUGINOSA AND BACTERIA OF BURKHOLDERIA CEPACIA COMPLEX, PERSISTING IN LUNGS OF PATIENTS WITH MUCOVISCIDOSIS (MV)].
    Avetisyan LR; Chernukha MY; Shaginyan IA; Kapranov NI; Siyanova EA; Medvedeva OS; Kondratieva EI; Alekseeva GV; Krasovsky SA; Usacheva MV; Amelina EL
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (6):3-10. PubMed ID: 26950982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of the Hmq System and Production of 4-Hydroxy-3-Methyl-2-Alkylquinolines Are Heterogeneously Distributed between Burkholderia cepacia Complex Species and More Prevalent among Environmental than Clinical Isolates.
    Coulon PML; Zlosnik JEA; Déziel E
    Microbiol Spectr; 2021 Sep; 9(1):e0012721. PubMed ID: 34132614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of co-colonizing cystic fibrosis-associated pathogens by Pseudomonas aeruginosa and Burkholderia multivorans.
    Costello A; Reen FJ; O'Gara F; Callaghan M; McClean S
    Microbiology (Reading); 2014 Jul; 160(Pt 7):1474-1487. PubMed ID: 24790091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis.
    Reik R; Spilker T; Lipuma JJ
    J Clin Microbiol; 2005 Jun; 43(6):2926-8. PubMed ID: 15956421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate.
    Dingemans J; Ghequire MG; Craggs M; De Mot R; Cornelis P
    Microbiologyopen; 2016 Jun; 5(3):413-23. PubMed ID: 26860427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous coinfection by multiple strains during Burkholderia cepacia complex infection in cystic fibrosis.
    Yang JH; Spilker T; LiPuma JJ
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):95-8. PubMed ID: 16406186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkholderia cepacia complex in cystic fibrosis in the post-epidemic period: multilocus sequence typing-based approach.
    Fila L; Dřevínek P
    Folia Microbiol (Praha); 2017 Nov; 62(6):509-514. PubMed ID: 28364392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular typing of Burkholderia cepacia complex isolated from patients attending an Italian Cystic Fibrosis Centre.
    Teri A; Sottotetti S; Biffi A; Girelli D; D'Accico M; Arghittu M; Colombo C; Corti F; Pizzamiglio G; Cariani L
    New Microbiol; 2018 Apr; 41(2):141-144. PubMed ID: 29498745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swimming motility in a longitudinal collection of clinical isolates of Burkholderia cepacia complex bacteria from people with cystic fibrosis.
    Zlosnik JE; Mori PY; To D; Leung J; Hird TJ; Speert DP
    PLoS One; 2014; 9(9):e106428. PubMed ID: 25203161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum.
    Martinucci M; Roscetto E; Iula VD; Votsi A; Catania MR; De Gregorio E
    Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis.
    Chen Y; Garber E; Zhao Q; Ge Y; Wikler MA; Kaniga K; Saiman L
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2510-1. PubMed ID: 15917558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species distribution of Burkholderia cepacia complex isolates in cystic fibrosis and non-cystic fibrosis patients in New Zealand.
    Pope CE; Short P; Carter PE
    J Cyst Fibros; 2010 Dec; 9(6):442-6. PubMed ID: 20833115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.